CD59 and diabetic kidney disease: Patients with DKD undergoing hemodialysis were shown to acquire a loss of several important regulators of complement activation, E-CR1, DAF, and CD59, when compared with patients undergoing hemodialysis with nondiabetic renal disease (157).